230 related articles for article (PubMed ID: 8970472)
1. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion.
Farzadegan H; Henrard DR; Kleeberger CA; Schrager L; Kirby AJ; Saah AJ; Rinaldo CR; O'Gorman M; Detels R; Taylor E; Phair JP; Margolick JB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(5):448-55. PubMed ID: 8970472
[TBL] [Abstract][Full Text] [Related]
2. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ
Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.
Mellors JW; Kingsley LA; Rinaldo CR; Todd JA; Hoo BS; Kokka RP; Gupta P
Ann Intern Med; 1995 Apr; 122(8):573-9. PubMed ID: 7887550
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome.
Katzenstein TL; Pedersen C; Nielsen C; Lundgren JD; Jakobsen PH; Gerstoft J
AIDS; 1996 Feb; 10(2):167-73. PubMed ID: 8838704
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression.
Baum LL; Cassutt KJ; Knigge K; Khattri R; Margolick J; Rinaldo C; Kleeberger CA; Nishanian P; Henrard DR; Phair J
J Immunol; 1996 Sep; 157(5):2168-73. PubMed ID: 8757343
[TBL] [Abstract][Full Text] [Related]
7. [ Biological criteria for prediction of the clinical course leading to AIDS].
Salmon D; Couroucé AM; Doinel C; Fine JM; Kaplan C; Lambin P; Lefrère JJ; Rouger P; Salmon C
Rev Fr Transfus Hemobiol; 1990 Dec; 33(6):407-14. PubMed ID: 1981002
[No Abstract] [Full Text] [Related]
8. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.
Zagury JF; Sill A; Blattner W; Lachgar A; Le Buanec H; Richardson M; Rappaport J; Hendel H; Bizzini B; Gringeri A; Carcagno M; Criscuolo M; Burny A; Gallo RC; Zagury D
J Hum Virol; 1998; 1(4):282-92. PubMed ID: 10195253
[TBL] [Abstract][Full Text] [Related]
9. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
10. Predictors of rapid progression to AIDS in HIV-1 seroconverters.
Keet IP; Krijnen P; Koot M; Lange JM; Miedema F; Goudsmit J; Coutinho RA
AIDS; 1993 Jan; 7(1):51-7. PubMed ID: 8095146
[TBL] [Abstract][Full Text] [Related]
11. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.
Hogervorst E; Jurriaans S; de Wolf F; van Wijk A; Wiersma A; Valk M; Roos M; van Gemen B; Coutinho R; Miedema F
J Infect Dis; 1995 Apr; 171(4):811-21. PubMed ID: 7706807
[TBL] [Abstract][Full Text] [Related]
12. Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression.
Shi M; Taylor JM; Fahey JL; Hoover DR; Muñoz A; Kingsley LA
J Clin Immunol; 1997 Jan; 17(1):43-52. PubMed ID: 9049785
[TBL] [Abstract][Full Text] [Related]
13. Tracking of markers and onset of disease among HIV-1 seroconverters.
Galai N; Muñoz A; Chen K; Carey VJ; Chmiel J; Zhou SY
Stat Med; 1993 Nov; 12(22):2133-45. PubMed ID: 7906051
[TBL] [Abstract][Full Text] [Related]
14. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection.
Henrard DR; Daar E; Farzadegan H; Clark SJ; Phillips J; Shaw GM; Busch MP
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):305-10. PubMed ID: 7788430
[TBL] [Abstract][Full Text] [Related]
15. Neopterin and beta-2 microglobulin levels in asymptomatic HIV infection: the predictive value of combining markers.
Harrison NA; Skidmore SJ
J Med Virol; 1990 Oct; 32(2):128-33. PubMed ID: 2126281
[TBL] [Abstract][Full Text] [Related]
16. Replacing time since human immunodeficiency virus infection by marker values in predicting residual time to acquired immunodeficiency syndrome diagnosis. Multicenter AIDS Cohort Study.
Shi M; Taylor JM; Currier RJ; Tang H; Hoover DR; Chmiel JS; Bryant JL
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):309-16. PubMed ID: 8673537
[TBL] [Abstract][Full Text] [Related]
17. Long-term HIV-1 infection without immunologic progression.
Buchbinder SP; Katz MH; Hessol NA; O'Malley PM; Holmberg SD
AIDS; 1994 Aug; 8(8):1123-8. PubMed ID: 7986410
[TBL] [Abstract][Full Text] [Related]
18. Earlier detection of human immunodeficiency virus type 1 p24 antigen and immunoglobulin G and M antibodies to p17 antigen in seroconversion serum panels by immune complex transfer enzyme immunoassays.
Hashida S; Ishikawa S; Hashinaka K; Nishikata I; Oka S; Ishikawa E
Clin Diagn Lab Immunol; 2000 Nov; 7(6):872-81. PubMed ID: 11063490
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.
Goedert JJ; Kessler CM; Aledort LM; Biggar RJ; Andes WA; White GC; Drummond JE; Vaidya K; Mann DL; Eyster ME
N Engl J Med; 1989 Oct; 321(17):1141-8. PubMed ID: 2477702
[TBL] [Abstract][Full Text] [Related]
20. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]